PPT-A New Era in Anticoagulation Management

Allyson Sarigianis PharmD October 19 2013 Objectives Review current practice recommendations for prevention of strokesystemic embolism in atrial fibrillation Compare and contrast pharmacology between warfarin and target specific oral anticoagulants TSOACs. Seven. Venous Disease Coalition. Long-Term Management of VTE. VTE . T. oolkit. Long-Term Treatment of DVT/PE:. 2 options. VTE . T. oolkit. LMWH S/C. Oral Anticoagulation (INR 2.0 - 3.0). 5-7 d. 3 . Brandon . McMahon,. MD. Venous . Thromboembolism. (VTE). ~950,000 cases of VTE annually (incident + recurrent). Rates expected to double by 2050. Mortality. 100,000 US deaths annually. 10-30% die within a month of diagnosis. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. . . Feb 08/2014. Hanadi. . Alhozali,MBBS,ABIM,FRCPC. Assistant professor consultant internal medicine and Nephrology KAUH/Jeddah. Glomerular- based disease and Renal disease in pregnancy. Objectives. Fibrillation. Michelle Tsukamoto . DSR 2 May 9, 2018. PGY 2. 1. Objectives. Discuss which patients with . atrial. fibrillation should be . anticoagulated. for CVA prevention. Learn about different oral anticoagulation options . Fibrillation. Michelle Tsukamoto . DSR 2 May 9, 2018. PGY 2. 1. Objectives. Discuss which patients with . atrial. fibrillation should be . anticoagulated. for CVA prevention. Learn about different oral anticoagulation options . . Alan Brush, MD, FACP. Chief, Anticoagulation Management Service. Harvard Vanguard Medical Associates. Language. . .. Suggestions . vs. . Recommendations: . based on the weight of evidence. Loading . Geoffrey Barnes, MD, MSc. University of Michigan. @. GBarnesMD. May 14, 2020. Disclosures. Grants: Pfizer/Bristol-Myers Squibb, Blue Cross Blue Shield of Michigan, NHLBI, AHRQ. Consulting: Pfizer/Bristol-Myers Squibb, Janssen, Portola, AMAG Pharmaceuticals. An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . E. ric. Tseng MD, . MScCH. , University of Toronto and . Paul . Figure 1 ). Management TheappropriatemanagementofAFisdependentupontheclinicalcontextinwhichitisencountered.Themajorityofcasescanbedealtwithappropriatelyonanoutpatientbasis.TheapproachtothetreatmentofA and Pulmonary Embolism. An Educational Slide Set . American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism. Slide set authors: . Zachary . Liederman. MD . MScCH. (University of Toronto). Educational Slides Set. American Society of Hematology 2021 . Authors: . Mario Luis Tejerina Valle, MD, . Caja. . Petrolera. de . Salud. - Bolivia. Juan Carlos Serrano Casas, MD, Universidad Central de Venezuela .  . Joshua P. Rainey. 1,3. , Olivia R. Palmer. 2. , Cathy Luke. 3. , José A. Diaz. 3. .  . 1. University of Michigan Medical School; . 2. Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI; . introduction. Twenty percent of maternal deaths in the United States during that period were attributed to PE.. . Inherited . thrombophilias. are associated with an increased risk of venous . thromboembolism.